Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 434 entries
View as:

Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00066482 Org: User:
Start: 07/31/04 End: - Due: -

Radiation Therapy in Treating Young Patients With Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT00238264 Org: User:
Start: 11/30/06 End: 12/31/18 Due: 12/31/19

DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00899652 Org: User:
Start: 01/31/97 End: 09/30/06 Due: 09/30/07

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00003141 Org: User:
Start: 03/31/98 End: 10/31/11 Due: 10/31/12

Studying Genes Using Cord Blood and Placenta Samples From Relatively Healthy Newborns and Samples From Younger Patients With Wilms Tumor

Phase: N/A Priority: Normal
NCT ID: NCT01576211 Org: User:
Start: 04/30/12 End: - Due: -

Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00618813 Org: User:
Start: 03/31/08 End: - Due: -

Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System

Phase: N/A Priority: Normal
NCT ID: NCT00653068 Org: User:
Start: 02/10/09 End: 03/31/24 Due: 03/31/25

Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01366170 Org: User:
Start: 05/31/11 End: - Due: -

Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)

Phase: N/A Priority: Normal
NCT ID: NCT00098839 Org: User:
Start: 02/28/05 End: 04/30/11 Due: 04/30/12

Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01353300 Org: User:
Start: 05/31/11 End: - Due: -

Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features

Phase: N/A Priority: Normal
NCT ID: NCT01048892 Org: User:
Start: 09/30/09 End: - Due: -

Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 Mutation

Phase: N/A Priority: Normal
NCT ID: NCT04203316 Org: User:
Start: 08/14/23 End: 06/30/25 Due: 06/30/26

Study of Blood Samples From Patients With Osteosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00954473 Org: User:
Start: 01/31/09 End: - Due: -

Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma

Phase: N/A Priority: Normal
NCT ID: NCT00028795 Org: User:
Start: 12/31/02 End: 03/31/12 Due: 03/31/13

Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01229956 Org: User:
Start: 11/30/10 End: - Due: -

Studying DNA in Samples From Younger Patients With Down Syndrome and Acute Myeloid Leukemia Treated on COG-AAML0431 Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT01507441 Org: User:
Start: 02/29/12 End: - Due: -

Biomarkers to Classify Young Patients With Acute Lymphoblastic Leukemia (ALL) and Remission Induction Therapy in Young Patients With B-Precursor ALL

Phase: N/A Priority: Normal
NCT ID: NCT01225874 Org: User:
Start: 12/31/99 End: - Due: -

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma

Phase: N/A Priority: Normal
NCT ID: NCT00003625 Org: User:
Start: 12/31/98 End: 04/30/06 Due: 04/30/07

Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00006462 Org: User:
Start: 04/30/01 End: 09/30/06 Due: 09/30/07

Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00469859 Org: User:
Start: 06/30/07 End: 03/31/10 Due: 03/31/11

Studying DNA in Blood and Bone Marrow Samples From Younger Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01024127 Org: User:
Start: 12/31/09 End: - Due: -

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00002740 Org: User:
Start: 05/31/96 End: 09/30/05 Due: 09/30/06

Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01520246 Org: User:
Start: 01/31/12 End: - Due: -

Ecteinascidin 743 in Treating Children With Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00006463 Org: User:
Start: 10/31/00 End: 09/30/05 Due: 09/30/06

Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00004056 Org: User:
Start: 10/31/99 End: 03/31/07 Due: 03/31/08